Teleflex Investor Presentation

Drive Sustainable Revenue Growth Balanced Portfolio with Multiple Market-Leading, High Growth Franchises -26%1 High Growth Portfolio The UroLift® System, Hemostatic Products, Arrow® EZ-IO® Intraosseous Vascular Access System, PICC Portfolio, Arrow OnControl® Powered Bone Access System, MANTAⓇ Vascular Closure Device, and Titan SGS® Stapler -64%1 ~10%1 Durable Core Other² Anesthesia, Interventional, OEM, Surgical, Vascular Access 1. As a percentage of 2022 revenue. 2. Includes revenue generated from the Company's respiratory and urology products (other than interventional urology products), and products sold to Medline pursuant to the manufacturing and supply transition agreement executed in June 2021. 8 Teleflex®

View entire presentation